Aryl-linked salicylaldoxime-based copper(II) helicates and "boxes": synthesis, X-ray analysis, and anion influence on complex structure.

The synthesis and spectroscopic analysis of both "metal-only" and anion encapsulated salicylaldoxime-based complexes utilizing a new 1,3-xylyl strap are described. X-ray crystallographic analysis reveals that the aromatic spacer restricts the confirmation flexibility of the resulting complexes leading to dicopper(II) double helicate and dicopper(II) 2 + 2 "box" structural forms. The choice of the structural motif is influenced by the anion present, with the copper(II) nitrate-containing complex [NO3⊂(Cu2L(3)2)](NO3)3, 4, adopting a double helicate form, whereas the analogous copper(II) bromide complexes [2Br⊂(Cu2L(3)2)](Br)2, 5, and [2Br⊂(Cu2L(3)2)](BF4)2, 6, both adopt 2 + 2 "box" structural configurations. Spectroscopic analysis has shown an enhancement in the binding strength of ClO4(-) over the anions SO4(2-) and NO3(-). The enhanced rigidity caused by the use of the 1,3-xylyl spacer in this series of complexes has favored the formation of the "double loaded" dibromide complex.

Anion-driven conformation control and enhanced sulfate binding utilising aryl linked salicylaldoxime dicopper helicates.

The synthesis and spectroscopic analysis of both "metal-only" and anion encapsulated dicopper(II) double helicates utilising a new 1,4-aryl spacer is described. X-Ray crystallographic analysis of the complexes reveal that the aromatic spacer increases rigidity in the complex, yet the complexes are still able to undergo a dramatic "coiling up" to bind anions. Spectroscopic analysis has shown a clear enhancement in the binding strength of SO(4)(2-) over the non-coordinating anions ClO(4)(-), NO(3)(-) and Br(-) which has been attributed to a combination of enhanced rigidity in the complex and an increased electrostatic interaction between the complex and the dianion.

Adiponectin levels are reduced, independent of polymorphisms in the adiponectin gene, after supplementation with alpha-linolenic acid among healthy adults.

Our first aim was to determine whether an isocaloric intervention using alpha-linolenic acid (ALA) in the form of flaxseed oil would alter adiponectin levels among overweight, otherwise healthy, males and females, and our second aim was to test for any potential modification of this intervention by 2 single nucleotide polymorphisms (276 and 45) in the adiponectin gene. Subjects included healthy adult males and females (approximately 81% female; average age, 38 years) with increased waist circumference (mean, 99 cm) and body mass index (mean, 30 kg/m(2)) who were free of chronic disease, not taking medications, and sedentary. Subjects met weekly with a registered dietician for 8 weeks. The control subjects (n = 27) were instructed not to alter their habitual diet and the ALA group (n = 30) was instructed to follow an enriched ALA diet by using flaxseed oil capsules (increasing ALA to 5% of total energy intake) and to lower their dietary fat consumption by a commensurate amount. Diets were analyzed using the Food Intake and Analysis System (v. 3.0, University of Texas School of Public Health, 1998). Fasting blood samples were obtained before and after the 8-week intervention. We found significant decreases (P = .02) in adiponectin (10.12 microg/mL pre, 9.23 microg/mL post) in the ALA group as compared with the control group (7.93 microg/mL pre, 8.10 microg/mL post) after the intervention. We also saw a decline in adiponectin in all genotype groups with the greatest decline among those carrying the rare T allele of single nucleotide polymorphism 276. There were no significant changes in fasting insulin, glucose, or quantitative insulin sensitivity check index values as a result of this intervention. In conclusion, this study suggests that supplementing with ALA for 8 weeks may lower adiponectin levels among healthy individuals, and this effect appears to be independent of polymorphisms in the adiponectin gene. Although the change in adiponectin in response to the omega-3 fatty acids was not accompanied by any change in glucose, insulin, or quantitative insulin sensitivity check index, long-term implications of such a decrease should be considered in future studies.

Inflammatory markers are not altered by an eight week dietary alpha-linolenic acid intervention in healthy abdominally obese adult males and females.

Atherogenesis is thought to be mediated by local and/or systemic production of pro-inflammatory cytokines and omega-3 fatty acids have been implicated in reducing these inflammatory markers. The objective of this study was to determine the effect of an isocaloric diet supplemented with a plant-based dietary omega-3 fatty acid [alpha-linolenic acid (ALA)] on interleukin-6, C-reactive protein, serum amyloid A, and tumor necrosis factor-alpha. Subjects included healthy adult males and females (approximately 79% female, average age 38 years) with increased waist circumference (mean WC=99 cm) and body mass index (mean BMI=29.8 kg/m(2)) who were free of chronic disease, not taking medications, and sedentary. Control subjects (n=24) did not to alter their habitual diet and the ALA group (n=27) followed an enriched ALA diet by using flaxseed oil capsules (increasing ALA to 5% of total energy intake) and lowered their dietary fat consumption by a commensurate amount. Fasting blood samples were obtained before and after the 8-week intervention. We found no significant changes in the inflammatory factors after this 8-week dietary intervention. This study suggests there are no beneficial effects of an 8-week ALA intervention on these inflammatory factors among young, healthy, overweight/obese subjects whose inflammatory factors are not significantly elevated.